Global Medical Weight Loss Drug Market Growth 2026-2032
The global Medical Weight Loss Drug market size is predicted to grow from US$ 23967 million in 2025 to US$ 62167 million in 2032; it is expected to grow at a CAGR of 14.2% from 2026 to 2032.
In 2025, global Medical Weight Loss Drug production reached approximately 29 million doses, with an average global market price of around USD 850 per dose.
The gross profit margin of major companies in the industry is between 55%–75%.
In 2025, the global production capacity of Medical Weight Loss Drug was approximately 38 million doses.
Medical Weight Loss Drug refers to prescription pharmaceutical products designed for obesity treatment and weight management under medical supervision. These drugs help regulate appetite, metabolism, and energy balance through specific mechanisms. They are mainly used for obesity patients and overweight populations with related health risks, including injectable and oral therapies. The product scope covers approved pharmaceutical treatments for weight reduction and excludes supplements, health foods, and non-drug weight loss products.
The industry chain includes upstream pharmaceutical materials, midstream drug development and manufacturing, and downstream medical applications. Upstream provides active pharmaceutical ingredients and related materials. Midstream focuses on research, formulation, production, and quality control. Downstream includes hospitals, clinics, pharmacies, and patients who require medical weight management treatments.
United States market for Medical Weight Loss Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Medical Weight Loss Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Medical Weight Loss Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Medical Weight Loss Drug players cover Novo Nordisk A/S, Eli Lilly and Company, Amgen Inc., Altimmune, Inc., Viking Therapeutics, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
This Insight Report provides a comprehensive analysis of the global Medical Weight Loss Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Weight Loss Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Weight Loss Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Weight Loss Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Weight Loss Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Weight Loss Drug market by product type, application, key manufacturers and key regions and countries.
In 2025, global Medical Weight Loss Drug production reached approximately 29 million doses, with an average global market price of around USD 850 per dose.
The gross profit margin of major companies in the industry is between 55%–75%.
In 2025, the global production capacity of Medical Weight Loss Drug was approximately 38 million doses.
Medical Weight Loss Drug refers to prescription pharmaceutical products designed for obesity treatment and weight management under medical supervision. These drugs help regulate appetite, metabolism, and energy balance through specific mechanisms. They are mainly used for obesity patients and overweight populations with related health risks, including injectable and oral therapies. The product scope covers approved pharmaceutical treatments for weight reduction and excludes supplements, health foods, and non-drug weight loss products.
The industry chain includes upstream pharmaceutical materials, midstream drug development and manufacturing, and downstream medical applications. Upstream provides active pharmaceutical ingredients and related materials. Midstream focuses on research, formulation, production, and quality control. Downstream includes hospitals, clinics, pharmacies, and patients who require medical weight management treatments.
United States market for Medical Weight Loss Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Medical Weight Loss Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Medical Weight Loss Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Medical Weight Loss Drug players cover Novo Nordisk A/S, Eli Lilly and Company, Amgen Inc., Altimmune, Inc., Viking Therapeutics, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Medical Weight Loss Drug Industry Forecast” looks at past sales and reviews total world Medical Weight Loss Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Medical Weight Loss Drug sales for 2026 through 2032. With Medical Weight Loss Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Weight Loss Drug industry.This Insight Report provides a comprehensive analysis of the global Medical Weight Loss Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Weight Loss Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Weight Loss Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Weight Loss Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Weight Loss Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Weight Loss Drug market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- GLP-1 Receptor Agonist Drugs
- Dual GIP/GLP-1 Receptor Agonist Drugs
- Other Metabolic Pathway Drugs
Segmentation by Administration Route:
- Injectable Weight Loss Drugs
- Oral Weight Loss Drugs
- Implantable Weight Loss Drugs
Segmentation by Dosage Form Strength:
- Low Dose Formulation (<5 mg per dose)
- Medium Dose Formulation (5–10 mg per dose)
- High Dose Formulation (>10 mg per dose)
Segmentation by Application:
- Obesity Treatment
- Overweight Management
- Weight-Related Metabolic Disease Treatment
- Other
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novo Nordisk A/S
- Eli Lilly and Company
- Amgen Inc.
- Altimmune, Inc.
- Viking Therapeutics, Inc.
- Structure Therapeutics Inc.
- Boehringer Ingelheim International GmbH
- Rhythm Pharmaceuticals, Inc.
- Pfizer Inc.
- Innovent Biologics, Inc.
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Shanghai Junshi Biosciences Co., Ltd.
- Hangzhou Jiuyuan Gene Engineering Co., Ltd.
- Haisco Pharmaceutical Group Co., Ltd.
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Tonghua Dongbao Pharmaceutical Co., Ltd.
- Gan & Lee Pharmaceuticals Co., Ltd.
- Huadong Medicine Co., Ltd.
- Livzon Pharmaceutical Group Inc.
- CSPC Pharmaceutical Group Limited
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Medical Weight Loss Drug market?
- What factors are driving Medical Weight Loss Drug market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Medical Weight Loss Drug market opportunities vary by end market size?
- How does Medical Weight Loss Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Medical Weight Loss Drug Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Medical Weight Loss Drug by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Medical Weight Loss Drug by Country/Region, 2021, 2025 & 2032
2.2 Medical Weight Loss Drug Segment by Type
2.2.1 GLP-1 Receptor Agonist Drugs
2.2.2 Dual GIP/GLP-1 Receptor Agonist Drugs
2.2.3 Other Metabolic Pathway Drugs
2.2.4 Medical Weight Loss Drug Sales by Type
2.2.4.1 Global Medical Weight Loss Drug Sales Market Share by Type (2021-2026)
2.2.4.2 Global Medical Weight Loss Drug Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Medical Weight Loss Drug Sale Price by Type (2021-2026)
2.3 Medical Weight Loss Drug Segment by Administration Route
2.3.1 Injectable Weight Loss Drugs
2.3.2 Oral Weight Loss Drugs
2.3.3 Implantable Weight Loss Drugs
2.3.4 Medical Weight Loss Drug Sales by Administration Route
2.3.4.1 Global Medical Weight Loss Drug Sales Market Share by Administration Route (2021-2026)
2.3.4.2 Global Medical Weight Loss Drug Revenue and Market Share by Administration Route (2021-2026)
2.3.4.3 Global Medical Weight Loss Drug Sale Price by Administration Route (2021-2026)
2.4 Medical Weight Loss Drug Segment by Dosage Form Strength
2.4.1 Low Dose Formulation (<5 mg per dose)
2.4.2 Medium Dose Formulation (5–10 mg per dose)
2.4.3 High Dose Formulation (>10 mg per dose)
2.4.4 Medical Weight Loss Drug Sales by Dosage Form Strength
2.4.4.1 Global Medical Weight Loss Drug Sales Market Share by Dosage Form Strength (2021-2026)
2.4.4.2 Global Medical Weight Loss Drug Revenue and Market Share by Dosage Form Strength (2021-2026)
2.4.4.3 Global Medical Weight Loss Drug Sale Price by Dosage Form Strength (2021-2026)
2.5 Medical Weight Loss Drug Segment by Application
2.5.1 Obesity Treatment
2.5.2 Overweight Management
2.5.3 Weight-Related Metabolic Disease Treatment
2.5.4 Other
2.5.5 Medical Weight Loss Drug Sales by Application
2.5.5.1 Global Medical Weight Loss Drug Sale Market Share by Application (2021-2026)
2.5.5.2 Global Medical Weight Loss Drug Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Medical Weight Loss Drug Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Medical Weight Loss Drug Breakdown Data by Company
3.1.1 Global Medical Weight Loss Drug Annual Sales by Company (2021-2026)
3.1.2 Global Medical Weight Loss Drug Sales Market Share by Company (2021-2026)
3.2 Global Medical Weight Loss Drug Annual Revenue by Company (2021-2026)
3.2.1 Global Medical Weight Loss Drug Revenue by Company (2021-2026)
3.2.2 Global Medical Weight Loss Drug Revenue Market Share by Company (2021-2026)
3.3 Global Medical Weight Loss Drug Sale Price by Company
3.4 Key Manufacturers Medical Weight Loss Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Weight Loss Drug Product Location Distribution
3.4.2 Players Medical Weight Loss Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MEDICAL WEIGHT LOSS DRUG BY GEOGRAPHIC REGION
4.1 World Historic Medical Weight Loss Drug Market Size by Geographic Region (2021-2026)
4.1.1 Global Medical Weight Loss Drug Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Medical Weight Loss Drug Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Medical Weight Loss Drug Market Size by Country/Region (2021-2026)
4.2.1 Global Medical Weight Loss Drug Annual Sales by Country/Region (2021-2026)
4.2.2 Global Medical Weight Loss Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Medical Weight Loss Drug Sales Growth
4.4 APAC Medical Weight Loss Drug Sales Growth
4.5 Europe Medical Weight Loss Drug Sales Growth
4.6 Middle East & Africa Medical Weight Loss Drug Sales Growth
5 AMERICAS
5.1 Americas Medical Weight Loss Drug Sales by Country
5.1.1 Americas Medical Weight Loss Drug Sales by Country (2021-2026)
5.1.2 Americas Medical Weight Loss Drug Revenue by Country (2021-2026)
5.2 Americas Medical Weight Loss Drug Sales by Type (2021-2026)
5.3 Americas Medical Weight Loss Drug Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Weight Loss Drug Sales by Region
6.1.1 APAC Medical Weight Loss Drug Sales by Region (2021-2026)
6.1.2 APAC Medical Weight Loss Drug Revenue by Region (2021-2026)
6.2 APAC Medical Weight Loss Drug Sales by Type (2021-2026)
6.3 APAC Medical Weight Loss Drug Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Medical Weight Loss Drug by Country
7.1.1 Europe Medical Weight Loss Drug Sales by Country (2021-2026)
7.1.2 Europe Medical Weight Loss Drug Revenue by Country (2021-2026)
7.2 Europe Medical Weight Loss Drug Sales by Type (2021-2026)
7.3 Europe Medical Weight Loss Drug Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Medical Weight Loss Drug by Country
8.1.1 Middle East & Africa Medical Weight Loss Drug Sales by Country (2021-2026)
8.1.2 Middle East & Africa Medical Weight Loss Drug Revenue by Country (2021-2026)
8.2 Middle East & Africa Medical Weight Loss Drug Sales by Type (2021-2026)
8.3 Middle East & Africa Medical Weight Loss Drug Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Weight Loss Drug
10.3 Manufacturing Process Analysis of Medical Weight Loss Drug
10.4 Industry Chain Structure of Medical Weight Loss Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Weight Loss Drug Distributors
11.3 Medical Weight Loss Drug Customer
12 WORLD FORECAST REVIEW FOR MEDICAL WEIGHT LOSS DRUG BY GEOGRAPHIC REGION
12.1 Global Medical Weight Loss Drug Market Size Forecast by Region
12.1.1 Global Medical Weight Loss Drug Forecast by Region (2027-2032)
12.1.2 Global Medical Weight Loss Drug Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Medical Weight Loss Drug Forecast by Type (2027-2032)
12.7 Global Medical Weight Loss Drug Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk A/S
13.1.1 Novo Nordisk A/S Company Information
13.1.2 Novo Nordisk A/S Medical Weight Loss Drug Product Portfolios and Specifications
13.1.3 Novo Nordisk A/S Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novo Nordisk A/S Main Business Overview
13.1.5 Novo Nordisk A/S Latest Developments
13.2 Eli Lilly and Company
13.2.1 Eli Lilly and Company Company Information
13.2.2 Eli Lilly and Company Medical Weight Loss Drug Product Portfolios and Specifications
13.2.3 Eli Lilly and Company Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Eli Lilly and Company Main Business Overview
13.2.5 Eli Lilly and Company Latest Developments
13.3 Amgen Inc.
13.3.1 Amgen Inc. Company Information
13.3.2 Amgen Inc. Medical Weight Loss Drug Product Portfolios and Specifications
13.3.3 Amgen Inc. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Amgen Inc. Main Business Overview
13.3.5 Amgen Inc. Latest Developments
13.4 Altimmune, Inc.
13.4.1 Altimmune, Inc. Company Information
13.4.2 Altimmune, Inc. Medical Weight Loss Drug Product Portfolios and Specifications
13.4.3 Altimmune, Inc. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Altimmune, Inc. Main Business Overview
13.4.5 Altimmune, Inc. Latest Developments
13.5 Viking Therapeutics, Inc.
13.5.1 Viking Therapeutics, Inc. Company Information
13.5.2 Viking Therapeutics, Inc. Medical Weight Loss Drug Product Portfolios and Specifications
13.5.3 Viking Therapeutics, Inc. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Viking Therapeutics, Inc. Main Business Overview
13.5.5 Viking Therapeutics, Inc. Latest Developments
13.6 Structure Therapeutics Inc.
13.6.1 Structure Therapeutics Inc. Company Information
13.6.2 Structure Therapeutics Inc. Medical Weight Loss Drug Product Portfolios and Specifications
13.6.3 Structure Therapeutics Inc. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Structure Therapeutics Inc. Main Business Overview
13.6.5 Structure Therapeutics Inc. Latest Developments
13.7 Boehringer Ingelheim International GmbH
13.7.1 Boehringer Ingelheim International GmbH Company Information
13.7.2 Boehringer Ingelheim International GmbH Medical Weight Loss Drug Product Portfolios and Specifications
13.7.3 Boehringer Ingelheim International GmbH Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Boehringer Ingelheim International GmbH Main Business Overview
13.7.5 Boehringer Ingelheim International GmbH Latest Developments
13.8 Rhythm Pharmaceuticals, Inc.
13.8.1 Rhythm Pharmaceuticals, Inc. Company Information
13.8.2 Rhythm Pharmaceuticals, Inc. Medical Weight Loss Drug Product Portfolios and Specifications
13.8.3 Rhythm Pharmaceuticals, Inc. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Rhythm Pharmaceuticals, Inc. Main Business Overview
13.8.5 Rhythm Pharmaceuticals, Inc. Latest Developments
13.9 Pfizer Inc.
13.9.1 Pfizer Inc. Company Information
13.9.2 Pfizer Inc. Medical Weight Loss Drug Product Portfolios and Specifications
13.9.3 Pfizer Inc. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Pfizer Inc. Main Business Overview
13.9.5 Pfizer Inc. Latest Developments
13.10 Innovent Biologics, Inc.
13.10.1 Innovent Biologics, Inc. Company Information
13.10.2 Innovent Biologics, Inc. Medical Weight Loss Drug Product Portfolios and Specifications
13.10.3 Innovent Biologics, Inc. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Innovent Biologics, Inc. Main Business Overview
13.10.5 Innovent Biologics, Inc. Latest Developments
13.11 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
13.11.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Company Information
13.11.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
13.11.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Main Business Overview
13.11.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Latest Developments
13.12 Shanghai Junshi Biosciences Co., Ltd.
13.12.1 Shanghai Junshi Biosciences Co., Ltd. Company Information
13.12.2 Shanghai Junshi Biosciences Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
13.12.3 Shanghai Junshi Biosciences Co., Ltd. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Shanghai Junshi Biosciences Co., Ltd. Main Business Overview
13.12.5 Shanghai Junshi Biosciences Co., Ltd. Latest Developments
13.13 Hangzhou Jiuyuan Gene Engineering Co., Ltd.
13.13.1 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Company Information
13.13.2 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
13.13.3 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Main Business Overview
13.13.5 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Latest Developments
13.14 Haisco Pharmaceutical Group Co., Ltd.
13.14.1 Haisco Pharmaceutical Group Co., Ltd. Company Information
13.14.2 Haisco Pharmaceutical Group Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
13.14.3 Haisco Pharmaceutical Group Co., Ltd. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Haisco Pharmaceutical Group Co., Ltd. Main Business Overview
13.14.5 Haisco Pharmaceutical Group Co., Ltd. Latest Developments
13.15 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
13.15.1 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Company Information
13.15.2 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
13.15.3 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Main Business Overview
13.15.5 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Latest Developments
13.16 Tonghua Dongbao Pharmaceutical Co., Ltd.
13.16.1 Tonghua Dongbao Pharmaceutical Co., Ltd. Company Information
13.16.2 Tonghua Dongbao Pharmaceutical Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
13.16.3 Tonghua Dongbao Pharmaceutical Co., Ltd. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Tonghua Dongbao Pharmaceutical Co., Ltd. Main Business Overview
13.16.5 Tonghua Dongbao Pharmaceutical Co., Ltd. Latest Developments
13.17 Gan & Lee Pharmaceuticals Co., Ltd.
13.17.1 Gan & Lee Pharmaceuticals Co., Ltd. Company Information
13.17.2 Gan & Lee Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
13.17.3 Gan & Lee Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Gan & Lee Pharmaceuticals Co., Ltd. Main Business Overview
13.17.5 Gan & Lee Pharmaceuticals Co., Ltd. Latest Developments
13.18 Huadong Medicine Co., Ltd.
13.18.1 Huadong Medicine Co., Ltd. Company Information
13.18.2 Huadong Medicine Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
13.18.3 Huadong Medicine Co., Ltd. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Huadong Medicine Co., Ltd. Main Business Overview
13.18.5 Huadong Medicine Co., Ltd. Latest Developments
13.19 Livzon Pharmaceutical Group Inc.
13.19.1 Livzon Pharmaceutical Group Inc. Company Information
13.19.2 Livzon Pharmaceutical Group Inc. Medical Weight Loss Drug Product Portfolios and Specifications
13.19.3 Livzon Pharmaceutical Group Inc. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Livzon Pharmaceutical Group Inc. Main Business Overview
13.19.5 Livzon Pharmaceutical Group Inc. Latest Developments
13.20 CSPC Pharmaceutical Group Limited
13.20.1 CSPC Pharmaceutical Group Limited Company Information
13.20.2 CSPC Pharmaceutical Group Limited Medical Weight Loss Drug Product Portfolios and Specifications
13.20.3 CSPC Pharmaceutical Group Limited Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 CSPC Pharmaceutical Group Limited Main Business Overview
13.20.5 CSPC Pharmaceutical Group Limited Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Medical Weight Loss Drug Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Medical Weight Loss Drug by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Medical Weight Loss Drug by Country/Region, 2021, 2025 & 2032
2.2 Medical Weight Loss Drug Segment by Type
2.2.1 GLP-1 Receptor Agonist Drugs
2.2.2 Dual GIP/GLP-1 Receptor Agonist Drugs
2.2.3 Other Metabolic Pathway Drugs
2.2.4 Medical Weight Loss Drug Sales by Type
2.2.4.1 Global Medical Weight Loss Drug Sales Market Share by Type (2021-2026)
2.2.4.2 Global Medical Weight Loss Drug Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Medical Weight Loss Drug Sale Price by Type (2021-2026)
2.3 Medical Weight Loss Drug Segment by Administration Route
2.3.1 Injectable Weight Loss Drugs
2.3.2 Oral Weight Loss Drugs
2.3.3 Implantable Weight Loss Drugs
2.3.4 Medical Weight Loss Drug Sales by Administration Route
2.3.4.1 Global Medical Weight Loss Drug Sales Market Share by Administration Route (2021-2026)
2.3.4.2 Global Medical Weight Loss Drug Revenue and Market Share by Administration Route (2021-2026)
2.3.4.3 Global Medical Weight Loss Drug Sale Price by Administration Route (2021-2026)
2.4 Medical Weight Loss Drug Segment by Dosage Form Strength
2.4.1 Low Dose Formulation (<5 mg per dose)
2.4.2 Medium Dose Formulation (5–10 mg per dose)
2.4.3 High Dose Formulation (>10 mg per dose)
2.4.4 Medical Weight Loss Drug Sales by Dosage Form Strength
2.4.4.1 Global Medical Weight Loss Drug Sales Market Share by Dosage Form Strength (2021-2026)
2.4.4.2 Global Medical Weight Loss Drug Revenue and Market Share by Dosage Form Strength (2021-2026)
2.4.4.3 Global Medical Weight Loss Drug Sale Price by Dosage Form Strength (2021-2026)
2.5 Medical Weight Loss Drug Segment by Application
2.5.1 Obesity Treatment
2.5.2 Overweight Management
2.5.3 Weight-Related Metabolic Disease Treatment
2.5.4 Other
2.5.5 Medical Weight Loss Drug Sales by Application
2.5.5.1 Global Medical Weight Loss Drug Sale Market Share by Application (2021-2026)
2.5.5.2 Global Medical Weight Loss Drug Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Medical Weight Loss Drug Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Medical Weight Loss Drug Breakdown Data by Company
3.1.1 Global Medical Weight Loss Drug Annual Sales by Company (2021-2026)
3.1.2 Global Medical Weight Loss Drug Sales Market Share by Company (2021-2026)
3.2 Global Medical Weight Loss Drug Annual Revenue by Company (2021-2026)
3.2.1 Global Medical Weight Loss Drug Revenue by Company (2021-2026)
3.2.2 Global Medical Weight Loss Drug Revenue Market Share by Company (2021-2026)
3.3 Global Medical Weight Loss Drug Sale Price by Company
3.4 Key Manufacturers Medical Weight Loss Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Weight Loss Drug Product Location Distribution
3.4.2 Players Medical Weight Loss Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MEDICAL WEIGHT LOSS DRUG BY GEOGRAPHIC REGION
4.1 World Historic Medical Weight Loss Drug Market Size by Geographic Region (2021-2026)
4.1.1 Global Medical Weight Loss Drug Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Medical Weight Loss Drug Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Medical Weight Loss Drug Market Size by Country/Region (2021-2026)
4.2.1 Global Medical Weight Loss Drug Annual Sales by Country/Region (2021-2026)
4.2.2 Global Medical Weight Loss Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Medical Weight Loss Drug Sales Growth
4.4 APAC Medical Weight Loss Drug Sales Growth
4.5 Europe Medical Weight Loss Drug Sales Growth
4.6 Middle East & Africa Medical Weight Loss Drug Sales Growth
5 AMERICAS
5.1 Americas Medical Weight Loss Drug Sales by Country
5.1.1 Americas Medical Weight Loss Drug Sales by Country (2021-2026)
5.1.2 Americas Medical Weight Loss Drug Revenue by Country (2021-2026)
5.2 Americas Medical Weight Loss Drug Sales by Type (2021-2026)
5.3 Americas Medical Weight Loss Drug Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Weight Loss Drug Sales by Region
6.1.1 APAC Medical Weight Loss Drug Sales by Region (2021-2026)
6.1.2 APAC Medical Weight Loss Drug Revenue by Region (2021-2026)
6.2 APAC Medical Weight Loss Drug Sales by Type (2021-2026)
6.3 APAC Medical Weight Loss Drug Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Medical Weight Loss Drug by Country
7.1.1 Europe Medical Weight Loss Drug Sales by Country (2021-2026)
7.1.2 Europe Medical Weight Loss Drug Revenue by Country (2021-2026)
7.2 Europe Medical Weight Loss Drug Sales by Type (2021-2026)
7.3 Europe Medical Weight Loss Drug Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Medical Weight Loss Drug by Country
8.1.1 Middle East & Africa Medical Weight Loss Drug Sales by Country (2021-2026)
8.1.2 Middle East & Africa Medical Weight Loss Drug Revenue by Country (2021-2026)
8.2 Middle East & Africa Medical Weight Loss Drug Sales by Type (2021-2026)
8.3 Middle East & Africa Medical Weight Loss Drug Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Weight Loss Drug
10.3 Manufacturing Process Analysis of Medical Weight Loss Drug
10.4 Industry Chain Structure of Medical Weight Loss Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Weight Loss Drug Distributors
11.3 Medical Weight Loss Drug Customer
12 WORLD FORECAST REVIEW FOR MEDICAL WEIGHT LOSS DRUG BY GEOGRAPHIC REGION
12.1 Global Medical Weight Loss Drug Market Size Forecast by Region
12.1.1 Global Medical Weight Loss Drug Forecast by Region (2027-2032)
12.1.2 Global Medical Weight Loss Drug Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Medical Weight Loss Drug Forecast by Type (2027-2032)
12.7 Global Medical Weight Loss Drug Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk A/S
13.1.1 Novo Nordisk A/S Company Information
13.1.2 Novo Nordisk A/S Medical Weight Loss Drug Product Portfolios and Specifications
13.1.3 Novo Nordisk A/S Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novo Nordisk A/S Main Business Overview
13.1.5 Novo Nordisk A/S Latest Developments
13.2 Eli Lilly and Company
13.2.1 Eli Lilly and Company Company Information
13.2.2 Eli Lilly and Company Medical Weight Loss Drug Product Portfolios and Specifications
13.2.3 Eli Lilly and Company Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Eli Lilly and Company Main Business Overview
13.2.5 Eli Lilly and Company Latest Developments
13.3 Amgen Inc.
13.3.1 Amgen Inc. Company Information
13.3.2 Amgen Inc. Medical Weight Loss Drug Product Portfolios and Specifications
13.3.3 Amgen Inc. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Amgen Inc. Main Business Overview
13.3.5 Amgen Inc. Latest Developments
13.4 Altimmune, Inc.
13.4.1 Altimmune, Inc. Company Information
13.4.2 Altimmune, Inc. Medical Weight Loss Drug Product Portfolios and Specifications
13.4.3 Altimmune, Inc. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Altimmune, Inc. Main Business Overview
13.4.5 Altimmune, Inc. Latest Developments
13.5 Viking Therapeutics, Inc.
13.5.1 Viking Therapeutics, Inc. Company Information
13.5.2 Viking Therapeutics, Inc. Medical Weight Loss Drug Product Portfolios and Specifications
13.5.3 Viking Therapeutics, Inc. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Viking Therapeutics, Inc. Main Business Overview
13.5.5 Viking Therapeutics, Inc. Latest Developments
13.6 Structure Therapeutics Inc.
13.6.1 Structure Therapeutics Inc. Company Information
13.6.2 Structure Therapeutics Inc. Medical Weight Loss Drug Product Portfolios and Specifications
13.6.3 Structure Therapeutics Inc. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Structure Therapeutics Inc. Main Business Overview
13.6.5 Structure Therapeutics Inc. Latest Developments
13.7 Boehringer Ingelheim International GmbH
13.7.1 Boehringer Ingelheim International GmbH Company Information
13.7.2 Boehringer Ingelheim International GmbH Medical Weight Loss Drug Product Portfolios and Specifications
13.7.3 Boehringer Ingelheim International GmbH Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Boehringer Ingelheim International GmbH Main Business Overview
13.7.5 Boehringer Ingelheim International GmbH Latest Developments
13.8 Rhythm Pharmaceuticals, Inc.
13.8.1 Rhythm Pharmaceuticals, Inc. Company Information
13.8.2 Rhythm Pharmaceuticals, Inc. Medical Weight Loss Drug Product Portfolios and Specifications
13.8.3 Rhythm Pharmaceuticals, Inc. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Rhythm Pharmaceuticals, Inc. Main Business Overview
13.8.5 Rhythm Pharmaceuticals, Inc. Latest Developments
13.9 Pfizer Inc.
13.9.1 Pfizer Inc. Company Information
13.9.2 Pfizer Inc. Medical Weight Loss Drug Product Portfolios and Specifications
13.9.3 Pfizer Inc. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Pfizer Inc. Main Business Overview
13.9.5 Pfizer Inc. Latest Developments
13.10 Innovent Biologics, Inc.
13.10.1 Innovent Biologics, Inc. Company Information
13.10.2 Innovent Biologics, Inc. Medical Weight Loss Drug Product Portfolios and Specifications
13.10.3 Innovent Biologics, Inc. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Innovent Biologics, Inc. Main Business Overview
13.10.5 Innovent Biologics, Inc. Latest Developments
13.11 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
13.11.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Company Information
13.11.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
13.11.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Main Business Overview
13.11.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Latest Developments
13.12 Shanghai Junshi Biosciences Co., Ltd.
13.12.1 Shanghai Junshi Biosciences Co., Ltd. Company Information
13.12.2 Shanghai Junshi Biosciences Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
13.12.3 Shanghai Junshi Biosciences Co., Ltd. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Shanghai Junshi Biosciences Co., Ltd. Main Business Overview
13.12.5 Shanghai Junshi Biosciences Co., Ltd. Latest Developments
13.13 Hangzhou Jiuyuan Gene Engineering Co., Ltd.
13.13.1 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Company Information
13.13.2 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
13.13.3 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Main Business Overview
13.13.5 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Latest Developments
13.14 Haisco Pharmaceutical Group Co., Ltd.
13.14.1 Haisco Pharmaceutical Group Co., Ltd. Company Information
13.14.2 Haisco Pharmaceutical Group Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
13.14.3 Haisco Pharmaceutical Group Co., Ltd. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Haisco Pharmaceutical Group Co., Ltd. Main Business Overview
13.14.5 Haisco Pharmaceutical Group Co., Ltd. Latest Developments
13.15 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
13.15.1 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Company Information
13.15.2 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
13.15.3 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Main Business Overview
13.15.5 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Latest Developments
13.16 Tonghua Dongbao Pharmaceutical Co., Ltd.
13.16.1 Tonghua Dongbao Pharmaceutical Co., Ltd. Company Information
13.16.2 Tonghua Dongbao Pharmaceutical Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
13.16.3 Tonghua Dongbao Pharmaceutical Co., Ltd. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Tonghua Dongbao Pharmaceutical Co., Ltd. Main Business Overview
13.16.5 Tonghua Dongbao Pharmaceutical Co., Ltd. Latest Developments
13.17 Gan & Lee Pharmaceuticals Co., Ltd.
13.17.1 Gan & Lee Pharmaceuticals Co., Ltd. Company Information
13.17.2 Gan & Lee Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
13.17.3 Gan & Lee Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Gan & Lee Pharmaceuticals Co., Ltd. Main Business Overview
13.17.5 Gan & Lee Pharmaceuticals Co., Ltd. Latest Developments
13.18 Huadong Medicine Co., Ltd.
13.18.1 Huadong Medicine Co., Ltd. Company Information
13.18.2 Huadong Medicine Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
13.18.3 Huadong Medicine Co., Ltd. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Huadong Medicine Co., Ltd. Main Business Overview
13.18.5 Huadong Medicine Co., Ltd. Latest Developments
13.19 Livzon Pharmaceutical Group Inc.
13.19.1 Livzon Pharmaceutical Group Inc. Company Information
13.19.2 Livzon Pharmaceutical Group Inc. Medical Weight Loss Drug Product Portfolios and Specifications
13.19.3 Livzon Pharmaceutical Group Inc. Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Livzon Pharmaceutical Group Inc. Main Business Overview
13.19.5 Livzon Pharmaceutical Group Inc. Latest Developments
13.20 CSPC Pharmaceutical Group Limited
13.20.1 CSPC Pharmaceutical Group Limited Company Information
13.20.2 CSPC Pharmaceutical Group Limited Medical Weight Loss Drug Product Portfolios and Specifications
13.20.3 CSPC Pharmaceutical Group Limited Medical Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 CSPC Pharmaceutical Group Limited Main Business Overview
13.20.5 CSPC Pharmaceutical Group Limited Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Medical Weight Loss Drug Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Medical Weight Loss Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of GLP-1 Receptor Agonist Drugs
Table 4. Major Players of Dual GIP/GLP-1 Receptor Agonist Drugs
Table 5. Major Players of Other Metabolic Pathway Drugs
Table 6. Global Medical Weight Loss Drug Sales by Type (2021-2026) & (K Dose)
Table 7. Global Medical Weight Loss Drug Sales Market Share by Type (2021-2026)
Table 8. Global Medical Weight Loss Drug Revenue by Type (2021-2026) & ($ million)
Table 9. Global Medical Weight Loss Drug Revenue Market Share by Type (2021-2026)
Table 10. Global Medical Weight Loss Drug Sale Price by Type (2021-2026) & (US$/Dose)
Table 11. Major Players of Injectable Weight Loss Drugs
Table 12. Major Players of Oral Weight Loss Drugs
Table 13. Major Players of Implantable Weight Loss Drugs
Table 14. Global Medical Weight Loss Drug Sales by Administration Route (2021-2026) & (K Dose)
Table 15. Global Medical Weight Loss Drug Sales Market Share by Administration Route (2021-2026)
Table 16. Global Medical Weight Loss Drug Revenue by Administration Route (2021-2026) & ($ million)
Table 17. Global Medical Weight Loss Drug Revenue Market Share by Administration Route (2021-2026)
Table 18. Global Medical Weight Loss Drug Sale Price by Administration Route (2021-2026) & (US$/Dose)
Table 19. Major Players of Low Dose Formulation (<5 mg per dose)
Table 20. Major Players of Medium Dose Formulation (5–10 mg per dose)
Table 21. Major Players of High Dose Formulation (>10 mg per dose)
Table 22. Global Medical Weight Loss Drug Sales by Dosage Form Strength (2021-2026) & (K Dose)
Table 23. Global Medical Weight Loss Drug Sales Market Share by Dosage Form Strength (2021-2026)
Table 24. Global Medical Weight Loss Drug Revenue by Dosage Form Strength (2021-2026) & ($ million)
Table 25. Global Medical Weight Loss Drug Revenue Market Share by Dosage Form Strength (2021-2026)
Table 26. Global Medical Weight Loss Drug Sale Price by Dosage Form Strength (2021-2026) & (US$/Dose)
Table 27. Global Medical Weight Loss Drug Sale by Application (2021-2026) & (K Dose)
Table 28. Global Medical Weight Loss Drug Sale Market Share by Application (2021-2026)
Table 29. Global Medical Weight Loss Drug Revenue by Application (2021-2026) & ($ million)
Table 30. Global Medical Weight Loss Drug Revenue Market Share by Application (2021-2026)
Table 31. Global Medical Weight Loss Drug Sale Price by Application (2021-2026) & (US$/Dose)
Table 32. Global Medical Weight Loss Drug Sales by Company (2021-2026) & (K Dose)
Table 33. Global Medical Weight Loss Drug Sales Market Share by Company (2021-2026)
Table 34. Global Medical Weight Loss Drug Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Medical Weight Loss Drug Revenue Market Share by Company (2021-2026)
Table 36. Global Medical Weight Loss Drug Sale Price by Company (2021-2026) & (US$/Dose)
Table 37. Key Manufacturers Medical Weight Loss Drug Producing Area Distribution and Sales Area
Table 38. Players Medical Weight Loss Drug Products Offered
Table 39. Medical Weight Loss Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Medical Weight Loss Drug Sales by Geographic Region (2021-2026) & (K Dose)
Table 43. Global Medical Weight Loss Drug Sales Market Share Geographic Region (2021-2026)
Table 44. Global Medical Weight Loss Drug Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Medical Weight Loss Drug Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Medical Weight Loss Drug Sales by Country/Region (2021-2026) & (K Dose)
Table 47. Global Medical Weight Loss Drug Sales Market Share by Country/Region (2021-2026)
Table 48. Global Medical Weight Loss Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Medical Weight Loss Drug Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Medical Weight Loss Drug Sales by Country (2021-2026) & (K Dose)
Table 51. Americas Medical Weight Loss Drug Sales Market Share by Country (2021-2026)
Table 52. Americas Medical Weight Loss Drug Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Medical Weight Loss Drug Sales by Type (2021-2026) & (K Dose)
Table 54. Americas Medical Weight Loss Drug Sales by Application (2021-2026) & (K Dose)
Table 55. APAC Medical Weight Loss Drug Sales by Region (2021-2026) & (K Dose)
Table 56. APAC Medical Weight Loss Drug Sales Market Share by Region (2021-2026)
Table 57. APAC Medical Weight Loss Drug Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Medical Weight Loss Drug Sales by Type (2021-2026) & (K Dose)
Table 59. APAC Medical Weight Loss Drug Sales by Application (2021-2026) & (K Dose)
Table 60. Europe Medical Weight Loss Drug Sales by Country (2021-2026) & (K Dose)
Table 61. Europe Medical Weight Loss Drug Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Medical Weight Loss Drug Sales by Type (2021-2026) & (K Dose)
Table 63. Europe Medical Weight Loss Drug Sales by Application (2021-2026) & (K Dose)
Table 64. Middle East & Africa Medical Weight Loss Drug Sales by Country (2021-2026) & (K Dose)
Table 65. Middle East & Africa Medical Weight Loss Drug Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Medical Weight Loss Drug Sales by Type (2021-2026) & (K Dose)
Table 67. Middle East & Africa Medical Weight Loss Drug Sales by Application (2021-2026) & (K Dose)
Table 68. Key Market Drivers & Growth Opportunities of Medical Weight Loss Drug
Table 69. Key Market Challenges & Risks of Medical Weight Loss Drug
Table 70. Key Industry Trends of Medical Weight Loss Drug
Table 71. Medical Weight Loss Drug Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Medical Weight Loss Drug Distributors List
Table 74. Medical Weight Loss Drug Customer List
Table 75. Global Medical Weight Loss Drug Sales Forecast by Region (2027-2032) & (K Dose)
Table 76. Global Medical Weight Loss Drug Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Medical Weight Loss Drug Sales Forecast by Country (2027-2032) & (K Dose)
Table 78. Americas Medical Weight Loss Drug Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Medical Weight Loss Drug Sales Forecast by Region (2027-2032) & (K Dose)
Table 80. APAC Medical Weight Loss Drug Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Medical Weight Loss Drug Sales Forecast by Country (2027-2032) & (K Dose)
Table 82. Europe Medical Weight Loss Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Medical Weight Loss Drug Sales Forecast by Country (2027-2032) & (K Dose)
Table 84. Middle East & Africa Medical Weight Loss Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Medical Weight Loss Drug Sales Forecast by Type (2027-2032) & (K Dose)
Table 86. Global Medical Weight Loss Drug Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Medical Weight Loss Drug Sales Forecast by Application (2027-2032) & (K Dose)
Table 88. Global Medical Weight Loss Drug Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. Novo Nordisk A/S Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Novo Nordisk A/S Medical Weight Loss Drug Product Portfolios and Specifications
Table 91. Novo Nordisk A/S Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 92. Novo Nordisk A/S Main Business
Table 93. Novo Nordisk A/S Latest Developments
Table 94. Eli Lilly and Company Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Eli Lilly and Company Medical Weight Loss Drug Product Portfolios and Specifications
Table 96. Eli Lilly and Company Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 97. Eli Lilly and Company Main Business
Table 98. Eli Lilly and Company Latest Developments
Table 99. Amgen Inc. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Amgen Inc. Medical Weight Loss Drug Product Portfolios and Specifications
Table 101. Amgen Inc. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 102. Amgen Inc. Main Business
Table 103. Amgen Inc. Latest Developments
Table 104. Altimmune, Inc. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Altimmune, Inc. Medical Weight Loss Drug Product Portfolios and Specifications
Table 106. Altimmune, Inc. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 107. Altimmune, Inc. Main Business
Table 108. Altimmune, Inc. Latest Developments
Table 109. Viking Therapeutics, Inc. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. Viking Therapeutics, Inc. Medical Weight Loss Drug Product Portfolios and Specifications
Table 111. Viking Therapeutics, Inc. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 112. Viking Therapeutics, Inc. Main Business
Table 113. Viking Therapeutics, Inc. Latest Developments
Table 114. Structure Therapeutics Inc. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. Structure Therapeutics Inc. Medical Weight Loss Drug Product Portfolios and Specifications
Table 116. Structure Therapeutics Inc. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 117. Structure Therapeutics Inc. Main Business
Table 118. Structure Therapeutics Inc. Latest Developments
Table 119. Boehringer Ingelheim International GmbH Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Boehringer Ingelheim International GmbH Medical Weight Loss Drug Product Portfolios and Specifications
Table 121. Boehringer Ingelheim International GmbH Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 122. Boehringer Ingelheim International GmbH Main Business
Table 123. Boehringer Ingelheim International GmbH Latest Developments
Table 124. Rhythm Pharmaceuticals, Inc. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 125. Rhythm Pharmaceuticals, Inc. Medical Weight Loss Drug Product Portfolios and Specifications
Table 126. Rhythm Pharmaceuticals, Inc. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 127. Rhythm Pharmaceuticals, Inc. Main Business
Table 128. Rhythm Pharmaceuticals, Inc. Latest Developments
Table 129. Pfizer Inc. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 130. Pfizer Inc. Medical Weight Loss Drug Product Portfolios and Specifications
Table 131. Pfizer Inc. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 132. Pfizer Inc. Main Business
Table 133. Pfizer Inc. Latest Developments
Table 134. Innovent Biologics, Inc. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 135. Innovent Biologics, Inc. Medical Weight Loss Drug Product Portfolios and Specifications
Table 136. Innovent Biologics, Inc. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 137. Innovent Biologics, Inc. Main Business
Table 138. Innovent Biologics, Inc. Latest Developments
Table 139. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 140. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
Table 141. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 142. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Main Business
Table 143. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Latest Developments
Table 144. Shanghai Junshi Biosciences Co., Ltd. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 145. Shanghai Junshi Biosciences Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
Table 146. Shanghai Junshi Biosciences Co., Ltd. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 147. Shanghai Junshi Biosciences Co., Ltd. Main Business
Table 148. Shanghai Junshi Biosciences Co., Ltd. Latest Developments
Table 149. Hangzhou Jiuyuan Gene Engineering Co., Ltd. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 150. Hangzhou Jiuyuan Gene Engineering Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
Table 151. Hangzhou Jiuyuan Gene Engineering Co., Ltd. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 152. Hangzhou Jiuyuan Gene Engineering Co., Ltd. Main Business
Table 153. Hangzhou Jiuyuan Gene Engineering Co., Ltd. Latest Developments
Table 154. Haisco Pharmaceutical Group Co., Ltd. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 155. Haisco Pharmaceutical Group Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
Table 156. Haisco Pharmaceutical Group Co., Ltd. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 157. Haisco Pharmaceutical Group Co., Ltd. Main Business
Table 158. Haisco Pharmaceutical Group Co., Ltd. Latest Developments
Table 159. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 160. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
Table 161. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 162. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Main Business
Table 163. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Latest Developments
Table 164. Tonghua Dongbao Pharmaceutical Co., Ltd. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 165. Tonghua Dongbao Pharmaceutical Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
Table 166. Tonghua Dongbao Pharmaceutical Co., Ltd. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 167. Tonghua Dongbao Pharmaceutical Co., Ltd. Main Business
Table 168. Tonghua Dongbao Pharmaceutical Co., Ltd. Latest Developments
Table 169. Gan & Lee Pharmaceuticals Co., Ltd. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 170. Gan & Lee Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
Table 171. Gan & Lee Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 172. Gan & Lee Pharmaceuticals Co., Ltd. Main Business
Table 173. Gan & Lee Pharmaceuticals Co., Ltd. Latest Developments
Table 174. Huadong Medicine Co., Ltd. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 175. Huadong Medicine Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
Table 176. Huadong Medicine Co., Ltd. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 177. Huadong Medicine Co., Ltd. Main Business
Table 178. Huadong Medicine Co., Ltd. Latest Developments
Table 179. Livzon Pharmaceutical Group Inc. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 180. Livzon Pharmaceutical Group Inc. Medical Weight Loss Drug Product Portfolios and Specifications
Table 181. Livzon Pharmaceutical Group Inc. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 182. Livzon Pharmaceutical Group Inc. Main Business
Table 183. Livzon Pharmaceutical Group Inc. Latest Developments
Table 184. CSPC Pharmaceutical Group Limited Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 185. CSPC Pharmaceutical Group Limited Medical Weight Loss Drug Product Portfolios and Specifications
Table 186. CSPC Pharmaceutical Group Limited Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 187. CSPC Pharmaceutical Group Limited Main Business
Table 188. CSPC Pharmaceutical Group Limited Latest Developments
Table 1. Medical Weight Loss Drug Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Medical Weight Loss Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of GLP-1 Receptor Agonist Drugs
Table 4. Major Players of Dual GIP/GLP-1 Receptor Agonist Drugs
Table 5. Major Players of Other Metabolic Pathway Drugs
Table 6. Global Medical Weight Loss Drug Sales by Type (2021-2026) & (K Dose)
Table 7. Global Medical Weight Loss Drug Sales Market Share by Type (2021-2026)
Table 8. Global Medical Weight Loss Drug Revenue by Type (2021-2026) & ($ million)
Table 9. Global Medical Weight Loss Drug Revenue Market Share by Type (2021-2026)
Table 10. Global Medical Weight Loss Drug Sale Price by Type (2021-2026) & (US$/Dose)
Table 11. Major Players of Injectable Weight Loss Drugs
Table 12. Major Players of Oral Weight Loss Drugs
Table 13. Major Players of Implantable Weight Loss Drugs
Table 14. Global Medical Weight Loss Drug Sales by Administration Route (2021-2026) & (K Dose)
Table 15. Global Medical Weight Loss Drug Sales Market Share by Administration Route (2021-2026)
Table 16. Global Medical Weight Loss Drug Revenue by Administration Route (2021-2026) & ($ million)
Table 17. Global Medical Weight Loss Drug Revenue Market Share by Administration Route (2021-2026)
Table 18. Global Medical Weight Loss Drug Sale Price by Administration Route (2021-2026) & (US$/Dose)
Table 19. Major Players of Low Dose Formulation (<5 mg per dose)
Table 20. Major Players of Medium Dose Formulation (5–10 mg per dose)
Table 21. Major Players of High Dose Formulation (>10 mg per dose)
Table 22. Global Medical Weight Loss Drug Sales by Dosage Form Strength (2021-2026) & (K Dose)
Table 23. Global Medical Weight Loss Drug Sales Market Share by Dosage Form Strength (2021-2026)
Table 24. Global Medical Weight Loss Drug Revenue by Dosage Form Strength (2021-2026) & ($ million)
Table 25. Global Medical Weight Loss Drug Revenue Market Share by Dosage Form Strength (2021-2026)
Table 26. Global Medical Weight Loss Drug Sale Price by Dosage Form Strength (2021-2026) & (US$/Dose)
Table 27. Global Medical Weight Loss Drug Sale by Application (2021-2026) & (K Dose)
Table 28. Global Medical Weight Loss Drug Sale Market Share by Application (2021-2026)
Table 29. Global Medical Weight Loss Drug Revenue by Application (2021-2026) & ($ million)
Table 30. Global Medical Weight Loss Drug Revenue Market Share by Application (2021-2026)
Table 31. Global Medical Weight Loss Drug Sale Price by Application (2021-2026) & (US$/Dose)
Table 32. Global Medical Weight Loss Drug Sales by Company (2021-2026) & (K Dose)
Table 33. Global Medical Weight Loss Drug Sales Market Share by Company (2021-2026)
Table 34. Global Medical Weight Loss Drug Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Medical Weight Loss Drug Revenue Market Share by Company (2021-2026)
Table 36. Global Medical Weight Loss Drug Sale Price by Company (2021-2026) & (US$/Dose)
Table 37. Key Manufacturers Medical Weight Loss Drug Producing Area Distribution and Sales Area
Table 38. Players Medical Weight Loss Drug Products Offered
Table 39. Medical Weight Loss Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Medical Weight Loss Drug Sales by Geographic Region (2021-2026) & (K Dose)
Table 43. Global Medical Weight Loss Drug Sales Market Share Geographic Region (2021-2026)
Table 44. Global Medical Weight Loss Drug Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Medical Weight Loss Drug Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Medical Weight Loss Drug Sales by Country/Region (2021-2026) & (K Dose)
Table 47. Global Medical Weight Loss Drug Sales Market Share by Country/Region (2021-2026)
Table 48. Global Medical Weight Loss Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Medical Weight Loss Drug Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Medical Weight Loss Drug Sales by Country (2021-2026) & (K Dose)
Table 51. Americas Medical Weight Loss Drug Sales Market Share by Country (2021-2026)
Table 52. Americas Medical Weight Loss Drug Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Medical Weight Loss Drug Sales by Type (2021-2026) & (K Dose)
Table 54. Americas Medical Weight Loss Drug Sales by Application (2021-2026) & (K Dose)
Table 55. APAC Medical Weight Loss Drug Sales by Region (2021-2026) & (K Dose)
Table 56. APAC Medical Weight Loss Drug Sales Market Share by Region (2021-2026)
Table 57. APAC Medical Weight Loss Drug Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Medical Weight Loss Drug Sales by Type (2021-2026) & (K Dose)
Table 59. APAC Medical Weight Loss Drug Sales by Application (2021-2026) & (K Dose)
Table 60. Europe Medical Weight Loss Drug Sales by Country (2021-2026) & (K Dose)
Table 61. Europe Medical Weight Loss Drug Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Medical Weight Loss Drug Sales by Type (2021-2026) & (K Dose)
Table 63. Europe Medical Weight Loss Drug Sales by Application (2021-2026) & (K Dose)
Table 64. Middle East & Africa Medical Weight Loss Drug Sales by Country (2021-2026) & (K Dose)
Table 65. Middle East & Africa Medical Weight Loss Drug Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Medical Weight Loss Drug Sales by Type (2021-2026) & (K Dose)
Table 67. Middle East & Africa Medical Weight Loss Drug Sales by Application (2021-2026) & (K Dose)
Table 68. Key Market Drivers & Growth Opportunities of Medical Weight Loss Drug
Table 69. Key Market Challenges & Risks of Medical Weight Loss Drug
Table 70. Key Industry Trends of Medical Weight Loss Drug
Table 71. Medical Weight Loss Drug Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Medical Weight Loss Drug Distributors List
Table 74. Medical Weight Loss Drug Customer List
Table 75. Global Medical Weight Loss Drug Sales Forecast by Region (2027-2032) & (K Dose)
Table 76. Global Medical Weight Loss Drug Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Medical Weight Loss Drug Sales Forecast by Country (2027-2032) & (K Dose)
Table 78. Americas Medical Weight Loss Drug Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Medical Weight Loss Drug Sales Forecast by Region (2027-2032) & (K Dose)
Table 80. APAC Medical Weight Loss Drug Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Medical Weight Loss Drug Sales Forecast by Country (2027-2032) & (K Dose)
Table 82. Europe Medical Weight Loss Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Medical Weight Loss Drug Sales Forecast by Country (2027-2032) & (K Dose)
Table 84. Middle East & Africa Medical Weight Loss Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Medical Weight Loss Drug Sales Forecast by Type (2027-2032) & (K Dose)
Table 86. Global Medical Weight Loss Drug Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Medical Weight Loss Drug Sales Forecast by Application (2027-2032) & (K Dose)
Table 88. Global Medical Weight Loss Drug Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. Novo Nordisk A/S Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Novo Nordisk A/S Medical Weight Loss Drug Product Portfolios and Specifications
Table 91. Novo Nordisk A/S Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 92. Novo Nordisk A/S Main Business
Table 93. Novo Nordisk A/S Latest Developments
Table 94. Eli Lilly and Company Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Eli Lilly and Company Medical Weight Loss Drug Product Portfolios and Specifications
Table 96. Eli Lilly and Company Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 97. Eli Lilly and Company Main Business
Table 98. Eli Lilly and Company Latest Developments
Table 99. Amgen Inc. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Amgen Inc. Medical Weight Loss Drug Product Portfolios and Specifications
Table 101. Amgen Inc. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 102. Amgen Inc. Main Business
Table 103. Amgen Inc. Latest Developments
Table 104. Altimmune, Inc. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Altimmune, Inc. Medical Weight Loss Drug Product Portfolios and Specifications
Table 106. Altimmune, Inc. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 107. Altimmune, Inc. Main Business
Table 108. Altimmune, Inc. Latest Developments
Table 109. Viking Therapeutics, Inc. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. Viking Therapeutics, Inc. Medical Weight Loss Drug Product Portfolios and Specifications
Table 111. Viking Therapeutics, Inc. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 112. Viking Therapeutics, Inc. Main Business
Table 113. Viking Therapeutics, Inc. Latest Developments
Table 114. Structure Therapeutics Inc. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. Structure Therapeutics Inc. Medical Weight Loss Drug Product Portfolios and Specifications
Table 116. Structure Therapeutics Inc. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 117. Structure Therapeutics Inc. Main Business
Table 118. Structure Therapeutics Inc. Latest Developments
Table 119. Boehringer Ingelheim International GmbH Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Boehringer Ingelheim International GmbH Medical Weight Loss Drug Product Portfolios and Specifications
Table 121. Boehringer Ingelheim International GmbH Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 122. Boehringer Ingelheim International GmbH Main Business
Table 123. Boehringer Ingelheim International GmbH Latest Developments
Table 124. Rhythm Pharmaceuticals, Inc. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 125. Rhythm Pharmaceuticals, Inc. Medical Weight Loss Drug Product Portfolios and Specifications
Table 126. Rhythm Pharmaceuticals, Inc. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 127. Rhythm Pharmaceuticals, Inc. Main Business
Table 128. Rhythm Pharmaceuticals, Inc. Latest Developments
Table 129. Pfizer Inc. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 130. Pfizer Inc. Medical Weight Loss Drug Product Portfolios and Specifications
Table 131. Pfizer Inc. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 132. Pfizer Inc. Main Business
Table 133. Pfizer Inc. Latest Developments
Table 134. Innovent Biologics, Inc. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 135. Innovent Biologics, Inc. Medical Weight Loss Drug Product Portfolios and Specifications
Table 136. Innovent Biologics, Inc. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 137. Innovent Biologics, Inc. Main Business
Table 138. Innovent Biologics, Inc. Latest Developments
Table 139. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 140. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
Table 141. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 142. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Main Business
Table 143. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Latest Developments
Table 144. Shanghai Junshi Biosciences Co., Ltd. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 145. Shanghai Junshi Biosciences Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
Table 146. Shanghai Junshi Biosciences Co., Ltd. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 147. Shanghai Junshi Biosciences Co., Ltd. Main Business
Table 148. Shanghai Junshi Biosciences Co., Ltd. Latest Developments
Table 149. Hangzhou Jiuyuan Gene Engineering Co., Ltd. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 150. Hangzhou Jiuyuan Gene Engineering Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
Table 151. Hangzhou Jiuyuan Gene Engineering Co., Ltd. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 152. Hangzhou Jiuyuan Gene Engineering Co., Ltd. Main Business
Table 153. Hangzhou Jiuyuan Gene Engineering Co., Ltd. Latest Developments
Table 154. Haisco Pharmaceutical Group Co., Ltd. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 155. Haisco Pharmaceutical Group Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
Table 156. Haisco Pharmaceutical Group Co., Ltd. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 157. Haisco Pharmaceutical Group Co., Ltd. Main Business
Table 158. Haisco Pharmaceutical Group Co., Ltd. Latest Developments
Table 159. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 160. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
Table 161. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 162. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Main Business
Table 163. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Latest Developments
Table 164. Tonghua Dongbao Pharmaceutical Co., Ltd. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 165. Tonghua Dongbao Pharmaceutical Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
Table 166. Tonghua Dongbao Pharmaceutical Co., Ltd. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 167. Tonghua Dongbao Pharmaceutical Co., Ltd. Main Business
Table 168. Tonghua Dongbao Pharmaceutical Co., Ltd. Latest Developments
Table 169. Gan & Lee Pharmaceuticals Co., Ltd. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 170. Gan & Lee Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
Table 171. Gan & Lee Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 172. Gan & Lee Pharmaceuticals Co., Ltd. Main Business
Table 173. Gan & Lee Pharmaceuticals Co., Ltd. Latest Developments
Table 174. Huadong Medicine Co., Ltd. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 175. Huadong Medicine Co., Ltd. Medical Weight Loss Drug Product Portfolios and Specifications
Table 176. Huadong Medicine Co., Ltd. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 177. Huadong Medicine Co., Ltd. Main Business
Table 178. Huadong Medicine Co., Ltd. Latest Developments
Table 179. Livzon Pharmaceutical Group Inc. Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 180. Livzon Pharmaceutical Group Inc. Medical Weight Loss Drug Product Portfolios and Specifications
Table 181. Livzon Pharmaceutical Group Inc. Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 182. Livzon Pharmaceutical Group Inc. Main Business
Table 183. Livzon Pharmaceutical Group Inc. Latest Developments
Table 184. CSPC Pharmaceutical Group Limited Basic Information, Medical Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 185. CSPC Pharmaceutical Group Limited Medical Weight Loss Drug Product Portfolios and Specifications
Table 186. CSPC Pharmaceutical Group Limited Medical Weight Loss Drug Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 187. CSPC Pharmaceutical Group Limited Main Business
Table 188. CSPC Pharmaceutical Group Limited Latest Developments
LIST OF FIGURES
Figure 1. Picture of Medical Weight Loss Drug
Figure 2. Medical Weight Loss Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Medical Weight Loss Drug Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Medical Weight Loss Drug Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Medical Weight Loss Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Medical Weight Loss Drug Sales Market Share by Country/Region (2025)
Figure 10. Medical Weight Loss Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of GLP-1 Receptor Agonist Drugs
Figure 12. Product Picture of Dual GIP/GLP-1 Receptor Agonist Drugs
Figure 13. Product Picture of Other Metabolic Pathway Drugs
Figure 14. Global Medical Weight Loss Drug Sales Market Share by Type in 2026
Figure 15. Global Medical Weight Loss Drug Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Injectable Weight Loss Drugs
Figure 17. Product Picture of Oral Weight Loss Drugs
Figure 18. Product Picture of Implantable Weight Loss Drugs
Figure 19. Global Medical Weight Loss Drug Sales Market Share by Administration Route in 2026
Figure 20. Global Medical Weight Loss Drug Revenue Market Share by Administration Route (2021-2026)
Figure 21. Product Picture of Low Dose Formulation (<5 mg per dose)
Figure 22. Product Picture of Medium Dose Formulation (5–10 mg per dose)
Figure 23. Product Picture of High Dose Formulation (>10 mg per dose)
Figure 24. Global Medical Weight Loss Drug Sales Market Share by Dosage Form Strength in 2026
Figure 25. Global Medical Weight Loss Drug Revenue Market Share by Dosage Form Strength (2021-2026)
Figure 26. Medical Weight Loss Drug Consumed in Obesity Treatment
Figure 27. Global Medical Weight Loss Drug Market: Obesity Treatment (2021-2026) & (K Dose)
Figure 28. Medical Weight Loss Drug Consumed in Overweight Management
Figure 29. Global Medical Weight Loss Drug Market: Overweight Management (2021-2026) & (K Dose)
Figure 30. Medical Weight Loss Drug Consumed in Weight-Related Metabolic Disease Treatment
Figure 31. Global Medical Weight Loss Drug Market: Weight-Related Metabolic Disease Treatment (2021-2026) & (K Dose)
Figure 32. Medical Weight Loss Drug Consumed in Other
Figure 33. Global Medical Weight Loss Drug Market: Other (2021-2026) & (K Dose)
Figure 34. Global Medical Weight Loss Drug Sale Market Share by Application (2025)
Figure 35. Global Medical Weight Loss Drug Revenue Market Share by Application in 2025
Figure 36. Medical Weight Loss Drug Sales by Company in 2025 (K Dose)
Figure 37. Global Medical Weight Loss Drug Sales Market Share by Company in 2025
Figure 38. Medical Weight Loss Drug Revenue by Company in 2025 ($ millions)
Figure 39. Global Medical Weight Loss Drug Revenue Market Share by Company in 2025
Figure 40. Global Medical Weight Loss Drug Sales Market Share by Geographic Region (2021-2026)
Figure 41. Global Medical Weight Loss Drug Revenue Market Share by Geographic Region in 2025
Figure 42. Americas Medical Weight Loss Drug Sales 2021-2026 (K Dose)
Figure 43. Americas Medical Weight Loss Drug Revenue 2021-2026 ($ millions)
Figure 44. APAC Medical Weight Loss Drug Sales 2021-2026 (K Dose)
Figure 45. APAC Medical Weight Loss Drug Revenue 2021-2026 ($ millions)
Figure 46. Europe Medical Weight Loss Drug Sales 2021-2026 (K Dose)
Figure 47. Europe Medical Weight Loss Drug Revenue 2021-2026 ($ millions)
Figure 48. Middle East & Africa Medical Weight Loss Drug Sales 2021-2026 (K Dose)
Figure 49. Middle East & Africa Medical Weight Loss Drug Revenue 2021-2026 ($ millions)
Figure 50. Americas Medical Weight Loss Drug Sales Market Share by Country in 2025
Figure 51. Americas Medical Weight Loss Drug Revenue Market Share by Country (2021-2026)
Figure 52. Americas Medical Weight Loss Drug Sales Market Share by Type (2021-2026)
Figure 53. Americas Medical Weight Loss Drug Sales Market Share by Application (2021-2026)
Figure 54. United States Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 55. Canada Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 56. Mexico Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 57. Brazil Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 58. APAC Medical Weight Loss Drug Sales Market Share by Region in 2025
Figure 59. APAC Medical Weight Loss Drug Revenue Market Share by Region (2021-2026)
Figure 60. APAC Medical Weight Loss Drug Sales Market Share by Type (2021-2026)
Figure 61. APAC Medical Weight Loss Drug Sales Market Share by Application (2021-2026)
Figure 62. China Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 63. Japan Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 64. South Korea Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 65. Southeast Asia Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 66. India Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 67. Australia Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 68. China Taiwan Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 69. Europe Medical Weight Loss Drug Sales Market Share by Country in 2025
Figure 70. Europe Medical Weight Loss Drug Revenue Market Share by Country (2021-2026)
Figure 71. Europe Medical Weight Loss Drug Sales Market Share by Type (2021-2026)
Figure 72. Europe Medical Weight Loss Drug Sales Market Share by Application (2021-2026)
Figure 73. Germany Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 74. France Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 75. UK Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 76. Italy Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 77. Russia Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 78. Middle East & Africa Medical Weight Loss Drug Sales Market Share by Country (2021-2026)
Figure 79. Middle East & Africa Medical Weight Loss Drug Sales Market Share by Type (2021-2026)
Figure 80. Middle East & Africa Medical Weight Loss Drug Sales Market Share by Application (2021-2026)
Figure 81. Egypt Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 82. South Africa Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 83. Israel Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 84. Turkey Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 85. GCC Countries Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of Medical Weight Loss Drug in 2026
Figure 87. Manufacturing Process Analysis of Medical Weight Loss Drug
Figure 88. Industry Chain Structure of Medical Weight Loss Drug
Figure 89. Channels of Distribution
Figure 90. Global Medical Weight Loss Drug Sales Market Forecast by Region (2027-2032)
Figure 91. Global Medical Weight Loss Drug Revenue Market Share Forecast by Region (2027-2032)
Figure 92. Global Medical Weight Loss Drug Sales Market Share Forecast by Type (2027-2032)
Figure 93. Global Medical Weight Loss Drug Revenue Market Share Forecast by Type (2027-2032)
Figure 94. Global Medical Weight Loss Drug Sales Market Share Forecast by Application (2027-2032)
Figure 95. Global Medical Weight Loss Drug Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Medical Weight Loss Drug
Figure 2. Medical Weight Loss Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Medical Weight Loss Drug Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Medical Weight Loss Drug Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Medical Weight Loss Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Medical Weight Loss Drug Sales Market Share by Country/Region (2025)
Figure 10. Medical Weight Loss Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of GLP-1 Receptor Agonist Drugs
Figure 12. Product Picture of Dual GIP/GLP-1 Receptor Agonist Drugs
Figure 13. Product Picture of Other Metabolic Pathway Drugs
Figure 14. Global Medical Weight Loss Drug Sales Market Share by Type in 2026
Figure 15. Global Medical Weight Loss Drug Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Injectable Weight Loss Drugs
Figure 17. Product Picture of Oral Weight Loss Drugs
Figure 18. Product Picture of Implantable Weight Loss Drugs
Figure 19. Global Medical Weight Loss Drug Sales Market Share by Administration Route in 2026
Figure 20. Global Medical Weight Loss Drug Revenue Market Share by Administration Route (2021-2026)
Figure 21. Product Picture of Low Dose Formulation (<5 mg per dose)
Figure 22. Product Picture of Medium Dose Formulation (5–10 mg per dose)
Figure 23. Product Picture of High Dose Formulation (>10 mg per dose)
Figure 24. Global Medical Weight Loss Drug Sales Market Share by Dosage Form Strength in 2026
Figure 25. Global Medical Weight Loss Drug Revenue Market Share by Dosage Form Strength (2021-2026)
Figure 26. Medical Weight Loss Drug Consumed in Obesity Treatment
Figure 27. Global Medical Weight Loss Drug Market: Obesity Treatment (2021-2026) & (K Dose)
Figure 28. Medical Weight Loss Drug Consumed in Overweight Management
Figure 29. Global Medical Weight Loss Drug Market: Overweight Management (2021-2026) & (K Dose)
Figure 30. Medical Weight Loss Drug Consumed in Weight-Related Metabolic Disease Treatment
Figure 31. Global Medical Weight Loss Drug Market: Weight-Related Metabolic Disease Treatment (2021-2026) & (K Dose)
Figure 32. Medical Weight Loss Drug Consumed in Other
Figure 33. Global Medical Weight Loss Drug Market: Other (2021-2026) & (K Dose)
Figure 34. Global Medical Weight Loss Drug Sale Market Share by Application (2025)
Figure 35. Global Medical Weight Loss Drug Revenue Market Share by Application in 2025
Figure 36. Medical Weight Loss Drug Sales by Company in 2025 (K Dose)
Figure 37. Global Medical Weight Loss Drug Sales Market Share by Company in 2025
Figure 38. Medical Weight Loss Drug Revenue by Company in 2025 ($ millions)
Figure 39. Global Medical Weight Loss Drug Revenue Market Share by Company in 2025
Figure 40. Global Medical Weight Loss Drug Sales Market Share by Geographic Region (2021-2026)
Figure 41. Global Medical Weight Loss Drug Revenue Market Share by Geographic Region in 2025
Figure 42. Americas Medical Weight Loss Drug Sales 2021-2026 (K Dose)
Figure 43. Americas Medical Weight Loss Drug Revenue 2021-2026 ($ millions)
Figure 44. APAC Medical Weight Loss Drug Sales 2021-2026 (K Dose)
Figure 45. APAC Medical Weight Loss Drug Revenue 2021-2026 ($ millions)
Figure 46. Europe Medical Weight Loss Drug Sales 2021-2026 (K Dose)
Figure 47. Europe Medical Weight Loss Drug Revenue 2021-2026 ($ millions)
Figure 48. Middle East & Africa Medical Weight Loss Drug Sales 2021-2026 (K Dose)
Figure 49. Middle East & Africa Medical Weight Loss Drug Revenue 2021-2026 ($ millions)
Figure 50. Americas Medical Weight Loss Drug Sales Market Share by Country in 2025
Figure 51. Americas Medical Weight Loss Drug Revenue Market Share by Country (2021-2026)
Figure 52. Americas Medical Weight Loss Drug Sales Market Share by Type (2021-2026)
Figure 53. Americas Medical Weight Loss Drug Sales Market Share by Application (2021-2026)
Figure 54. United States Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 55. Canada Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 56. Mexico Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 57. Brazil Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 58. APAC Medical Weight Loss Drug Sales Market Share by Region in 2025
Figure 59. APAC Medical Weight Loss Drug Revenue Market Share by Region (2021-2026)
Figure 60. APAC Medical Weight Loss Drug Sales Market Share by Type (2021-2026)
Figure 61. APAC Medical Weight Loss Drug Sales Market Share by Application (2021-2026)
Figure 62. China Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 63. Japan Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 64. South Korea Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 65. Southeast Asia Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 66. India Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 67. Australia Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 68. China Taiwan Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 69. Europe Medical Weight Loss Drug Sales Market Share by Country in 2025
Figure 70. Europe Medical Weight Loss Drug Revenue Market Share by Country (2021-2026)
Figure 71. Europe Medical Weight Loss Drug Sales Market Share by Type (2021-2026)
Figure 72. Europe Medical Weight Loss Drug Sales Market Share by Application (2021-2026)
Figure 73. Germany Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 74. France Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 75. UK Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 76. Italy Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 77. Russia Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 78. Middle East & Africa Medical Weight Loss Drug Sales Market Share by Country (2021-2026)
Figure 79. Middle East & Africa Medical Weight Loss Drug Sales Market Share by Type (2021-2026)
Figure 80. Middle East & Africa Medical Weight Loss Drug Sales Market Share by Application (2021-2026)
Figure 81. Egypt Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 82. South Africa Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 83. Israel Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 84. Turkey Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 85. GCC Countries Medical Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of Medical Weight Loss Drug in 2026
Figure 87. Manufacturing Process Analysis of Medical Weight Loss Drug
Figure 88. Industry Chain Structure of Medical Weight Loss Drug
Figure 89. Channels of Distribution
Figure 90. Global Medical Weight Loss Drug Sales Market Forecast by Region (2027-2032)
Figure 91. Global Medical Weight Loss Drug Revenue Market Share Forecast by Region (2027-2032)
Figure 92. Global Medical Weight Loss Drug Sales Market Share Forecast by Type (2027-2032)
Figure 93. Global Medical Weight Loss Drug Revenue Market Share Forecast by Type (2027-2032)
Figure 94. Global Medical Weight Loss Drug Sales Market Share Forecast by Application (2027-2032)
Figure 95. Global Medical Weight Loss Drug Revenue Market Share Forecast by Application (2027-2032)
